Prime leaders appear on PCMA’s podcast on topic “Understanding the value of biosimilars”

Prime’s Dr. Joseph Leach and Jarrod Henshaw discuss the opportunity, how the company’s new MedDrive™ medical drug management product will help manage growing specialty spend

September 8, 2021
Today, spending on biologic drugs makes up 43% of total drug spending. This is a growing area of new innovation for a multitude of therapeutic areas, and also an area of growing cost. To increase the use of biosimilars, strategies must be implemented to focus on biologics and drive cost-savings. To share these strategies, Prime’s Dr. Joseph Leach, senior vice president and chief medical officer and Jarrod Henshaw, senior vice president and Innovation & Supply Chain Officer joined JC Scott, executive director of Pharmaceutical Care Management Association (PCMA) and host of The Pharmacy Benefit podcast. Prime Therapeutics recently announced a major program addressing the increased use of biosimilars. Henshaw explains the differences between traditional drugs vs. biologics and generics drugs vs. biosimilars. Both discuss what it means for biosimilars to be interchangeable, how they confront fears and misperceptions on biosimilars, what roles PBMs must play to drive the cost-savings from adoption of biosimilars, and how policies and incentives can encourage the use of biosimilars.

Listen to the podcast

Explore other previous podcasts by PCMA

Related news

Stories

June 11, 2024

New clinical program aims to address gaps in cystic fibrosis care

Prime/MRx GuidedHealth® program offers new clinical solution aimed at providing quality care for those with cystic fibrosis

Stories

June 6, 2024

Supporting those who serve: Prime employee recognized with Patriotic Employer Award

Phil Hedlof recently received the Employer Support of the Guard and Reserve’s Patriotic Employer Award for his support of Josh Halonen before and during military deployment

Stories

June 4, 2024

Five Prime/MRx employees chosen for Women’s Health Leadership (WHL) TRUST memberships

Recipients were determined based on their leadership attributes, dedication to the health care industry and commitment to advancing women in health care